Health Condition 1: H041- Other disorders of lacrimal gland
Conditions
Interventions
Intervention1: Topical medications, Cyclosporine and Lifitegrast eye drops will be advised to dry eye patients.: Two group of patients in our study. One group will receive Cyclosporine eye drops and t
Sponsors
Sankara Eye Hospital, Shivamogga
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients who are diagnosed to have Moderate or Severe Dry eye disease 2 Who are compliant to medication 3 Willing to give consent for study
Exclusion criteria
Exclusion criteria: 1 H/o using steroid eye drops in past one month 2 Presence of other ocular co morbidities - glaucoma, lid abnormalities 3 Presence of MGD 4 H/o ocular trauma or infection in past 3 months 5 Corneal disorders affecting sensitivity 6 H/o Contact lens usage in past 3 months 7 Pregnant and lactating mothers 8 H/o intraocular surgery, refractive surgery in past 3 months 9 Presence of allergic conjunctivitis 10 H/o viral keratitis 11 Presence of pterygium 12 H/o punctal plug usage in last 3 months 13 H/o Steven-Jonson Syndrome, Ocular Pemphigoid 14 H/o usage of topical cyclosporine in past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the objective parameters which includes Schirmer tear test, Tear Break Up Time, Corneal and Conjunctival fluorescein staining, in patients treated with 0.05 percent Cyclosporine versus 5 percent Lifitegrast in dry eye diseaseTimepoint: At presentation, Day 15 and Day 45 | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the subjective response (OSDI) in patients treated with 0.05% Cyclosporine versus 5% Lifitegrast in Dry eye diseaseTimepoint: At presentation, Day 15 and Day 45 | — |
Countries
India
Contacts
Public ContactDr Lakshitha N
Sankara Eye Hospital, Shivamogga
Outcome results
None listed